These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1757114)

  • 1. Pneumococcal conjugate vaccines.
    Peeters CC; Tenbergen-Meekes AM; Haagmans B; Evenberg D; Poolman JT; Zegers BJ; Rijkers GT
    Immunol Lett; 1991 Oct; 30(2):267-74. PubMed ID: 1757114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates.
    Peeters C; Tenbergen-Meekes AM; Poolmann J; Zegers B; Rijkers G
    Med Microbiol Immunol; 1992; 181(1):35-42. PubMed ID: 1579084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice.
    Peeters CC; Tenbergen-Meekes AM; Evenberg DE; Poolman JT; Zegers BJ; Rijkers GT
    J Immunol; 1991 Jun; 146(12):4308-14. PubMed ID: 2040803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.
    Paoletti LC; Kasper DL; Michon F; DiFabio J; Jennings HJ; Tosteson TD; Wessels MR
    J Clin Invest; 1992 Jan; 89(1):203-9. PubMed ID: 1729272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory B and T cell responses induced by serotype 4 Streptococcus pneumoniae vaccines: longitudinal analysis comparing responses elicited by free polysaccharide, conjugate and carrier.
    Deauvieau F; Dussurgey S; Rossignol D; de Montfort A; Burdin N; Guy B
    Vaccine; 2009 Dec; 28(2):576-82. PubMed ID: 19878751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity.
    Laferrière CA; Sood RK; de Muys JM; Michon F; Jennings HJ
    Vaccine; 1997 Feb; 15(2):179-86. PubMed ID: 9066036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide--protein conjugate vaccine is decreased by admixture of high doses of free saccharide.
    Peeters CC; Tenbergen-Meekes AM; Poolman JT; Zegers BJ; Rijkers GT
    Vaccine; 1992; 10(12):833-40. PubMed ID: 1455909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
    Anttila M; Eskola J; Ahman H; Käyhty H
    J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response.
    Rodriguez ME; van den Dobbelsteen GP; Oomen LA; de Weers O; van Buren L; Beurret M; Poolman JT; Hoogerhout P
    Vaccine; 1998 Dec; 16(20):1941-9. PubMed ID: 9796048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines.
    Peeters CC; Tenbergen-Meekes AM; Poolman JT; Beurret M; Zegers BJ; Rijkers GT
    Infect Immun; 1991 Oct; 59(10):3504-10. PubMed ID: 1894357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self heat-shock protein (hsp60) peptide serves in a conjugate vaccine against a lethal pneumococcal infection.
    Könen-Waisman S; Cohen A; Fridkin M; Cohen IR
    J Infect Dis; 1999 Feb; 179(2):403-13. PubMed ID: 9878025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of pneumococcal polysaccharide conjugate vaccine with long spacer arm.
    Wu D; Ji S; Hu T
    Vaccine; 2013 Nov; 31(48):5623-6. PubMed ID: 24120485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.
    Soininen A; Seppälä I; Nieminen T; Eskola J; Käyhty H
    Vaccine; 1999 Apr; 17(15-16):1889-97. PubMed ID: 10217586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates.
    Beuvery EC; van Rossum F; Nagel J
    Infect Immun; 1982 Jul; 37(1):15-22. PubMed ID: 6809623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein.
    Beuvery EC; Roy R; Kanhai V; Jennings HJ
    Dev Biol Stand; 1986; 65():197-204. PubMed ID: 3104115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice.
    Beuvery EC; van Delft RW; Miedema F; Kanhai V; Nagel J
    Infect Immun; 1983 Aug; 41(2):609-17. PubMed ID: 6409811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
    O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
    Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein.
    Michon F; Fusco PC; Minetti CA; Laude-Sharp M; Uitz C; Huang CH; D'Ambra AJ; Moore S; Remeta DP; Heron I; Blake MS
    Vaccine; 1998 Nov; 16(18):1732-41. PubMed ID: 9778749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines.
    Lockyer K; Gao F; Derrick JP; Bolgiano B
    Vaccine; 2015 Mar; 33(11):1345-52. PubMed ID: 25640334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Immunological Studies of Oligosaccharides that Consist of the Repeating Unit of Streptococcus pneumoniae Serotype 3 Capsular Polysaccharide.
    Xiong C; Feng S; Qiao Y; Guo Z; Gu G
    Chemistry; 2018 Jun; 24(32):8205-8216. PubMed ID: 29528515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.